These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 30546356

  • 1. Reconstruction of the Vancomycin-Susceptible Staphylococcus aureus Phenotype From a Vancomycin-Intermediate S. aureus XN108.
    Peng H, Rao Y, Yuan W, Zheng Y, Shang W, Hu Z, Yang Y, Tan L, Xiong K, Li S, Zhu J, Hu X, Hu Q, Rao X.
    Front Microbiol; 2018; 9():2955. PubMed ID: 30546356
    [Abstract] [Full Text] [Related]

  • 2. WalK(S221P), a naturally occurring mutation, confers vancomycin resistance in VISA strain XN108.
    Peng H, Hu Q, Shang W, Yuan J, Zhang X, Liu H, Zheng Y, Hu Z, Yang Y, Tan L, Li S, Hu X, Li M, Rao X.
    J Antimicrob Chemother; 2017 Apr 01; 72(4):1006-1013. PubMed ID: 27999059
    [Abstract] [Full Text] [Related]

  • 3. A vancomycin resistance-associated WalK(S221P) mutation attenuates the virulence of vancomycin-intermediate Staphylococcus aureus.
    Rao Y, Peng H, Shang W, Hu Z, Yang Y, Tan L, Li M, Zhou R, Rao X.
    J Adv Res; 2022 Sep 01; 40():167-178. PubMed ID: 36100324
    [Abstract] [Full Text] [Related]

  • 4. Complete Reconstitution of the Vancomycin-Intermediate Staphylococcus aureus Phenotype of Strain Mu50 in Vancomycin-Susceptible S. aureus.
    Katayama Y, Sekine M, Hishinuma T, Aiba Y, Hiramatsu K.
    Antimicrob Agents Chemother; 2016 Jun 01; 60(6):3730-42. PubMed ID: 27067329
    [Abstract] [Full Text] [Related]

  • 5. Molecular Events for Promotion of Vancomycin Resistance in Vancomycin Intermediate Staphylococcus aureus.
    Hu Q, Peng H, Rao X.
    Front Microbiol; 2016 Jun 01; 7():1601. PubMed ID: 27790199
    [Abstract] [Full Text] [Related]

  • 6. Novel Mutation Sites in the Development of Vancomycin- Intermediate Resistance in Staphylococcus aureus.
    Wang Y, Li X, Jiang L, Han W, Xie X, Jin Y, He X, Wu R.
    Front Microbiol; 2016 Jun 01; 7():2163. PubMed ID: 28119680
    [Abstract] [Full Text] [Related]

  • 7. A novel mutation of walK confers vancomycin-intermediate resistance in methicillin-susceptible Staphylococcus aureus.
    Zhu J, Liu B, Shu X, Sun B.
    Int J Med Microbiol; 2021 Feb 01; 311(2):151473. PubMed ID: 33445057
    [Abstract] [Full Text] [Related]

  • 8. walK and clpP mutations confer reduced vancomycin susceptibility in Staphylococcus aureus.
    Shoji M, Cui L, Iizuka R, Komoto A, Neoh HM, Watanabe Y, Hishinuma T, Hiramatsu K.
    Antimicrob Agents Chemother; 2011 Aug 01; 55(8):3870-81. PubMed ID: 21628539
    [Abstract] [Full Text] [Related]

  • 9. Genomic analysis reveals a point mutation in the two-component sensor gene graS that leads to intermediate vancomycin resistance in clinical Staphylococcus aureus.
    Howden BP, Stinear TP, Allen DL, Johnson PD, Ward PB, Davies JK.
    Antimicrob Agents Chemother; 2008 Oct 01; 52(10):3755-62. PubMed ID: 18644967
    [Abstract] [Full Text] [Related]

  • 10. The evolution of vancomycin intermediate Staphylococcus aureus (VISA) and heterogenous-VISA.
    Howden BP, Peleg AY, Stinear TP.
    Infect Genet Evol; 2014 Jan 01; 21():575-82. PubMed ID: 23567819
    [Abstract] [Full Text] [Related]

  • 11. Reduced susceptibility to vancomycin in isogenic Staphylococcus aureus strains of sequence type 59: tracking evolution and identifying mutations by whole-genome sequencing.
    Chen CJ, Lin MH, Shu JC, Lu JJ.
    J Antimicrob Chemother; 2014 Feb 01; 69(2):349-54. PubMed ID: 24092658
    [Abstract] [Full Text] [Related]

  • 12. IS256-Mediated Overexpression of the WalKR Two-Component System Regulon Contributes to Reduced Vancomycin Susceptibility in a Staphylococcus aureus Clinical Isolate.
    Kuroda M, Sekizuka T, Matsui H, Ohsuga J, Ohshima T, Hanaki H.
    Front Microbiol; 2019 Feb 01; 10():1882. PubMed ID: 31474962
    [Abstract] [Full Text] [Related]

  • 13. The effect of subinhibitory concentration of chlorhexidine on the evolution of vancomycin-intermediate Staphylococcus aureus and the induction of mutations in walKR and vraTSR systems.
    Baseri N, Najar-Peerayeh S, Bakhshi B.
    Infect Genet Evol; 2021 Jan 01; 87():104628. PubMed ID: 33171303
    [Abstract] [Full Text] [Related]

  • 14. Dissecting vancomycin-intermediate resistance in staphylococcus aureus using genome-wide association.
    Alam MT, Petit RA, Crispell EK, Thornton TA, Conneely KN, Jiang Y, Satola SW, Read TD.
    Genome Biol Evol; 2014 Apr 30; 6(5):1174-85. PubMed ID: 24787619
    [Abstract] [Full Text] [Related]

  • 15. A mutation of RNA polymerase β' subunit (RpoC) converts heterogeneously vancomycin-intermediate Staphylococcus aureus (hVISA) into "slow VISA".
    Matsuo M, Hishinuma T, Katayama Y, Hiramatsu K.
    Antimicrob Agents Chemother; 2015 Jul 30; 59(7):4215-25. PubMed ID: 25941225
    [Abstract] [Full Text] [Related]

  • 16. Phenotypic and Molecular Characterisation of Staphylococcus Aureus with Reduced Vancomycin Susceptibility Derivated in Vitro.
    Xu J, Pang L, Ma XX, Hu J, Tian Y, Yang YL, Sun DD.
    Open Med (Wars); 2018 Jul 30; 13():475-486. PubMed ID: 30426085
    [Abstract] [Full Text] [Related]

  • 17. Generation of a vancomycin-intermediate Staphylococcus aureus (VISA) strain by two amino acid exchanges in VraS.
    Berscheid A, François P, Strittmatter A, Gottschalk G, Schrenzel J, Sass P, Bierbaum G.
    J Antimicrob Chemother; 2014 Dec 30; 69(12):3190-8. PubMed ID: 25103491
    [Abstract] [Full Text] [Related]

  • 18. Identification of Lysine Succinylome and Acetylome in the Vancomycin-Intermediate Staphylococcus aureus XN108.
    Tan L, Yang Y, Shang W, Hu Z, Peng H, Li S, Hu X, Rao X.
    Microbiol Spectr; 2022 Dec 21; 10(6):e0348122. PubMed ID: 36374118
    [Abstract] [Full Text] [Related]

  • 19. Isolates with low-level vancomycin resistance associated with persistent methicillin-resistant Staphylococcus aureus bacteremia.
    Howden BP, Johnson PD, Ward PB, Stinear TP, Davies JK.
    Antimicrob Agents Chemother; 2006 Sep 21; 50(9):3039-47. PubMed ID: 16940100
    [Abstract] [Full Text] [Related]

  • 20. Role of stop codons in development and loss of vancomycin non-susceptibility in methicillin-resistant Staphylococcus aureus.
    Doddangoudar VC, O'Donoghue MM, Chong EY, Tsang DN, Boost MV.
    J Antimicrob Chemother; 2012 Sep 21; 67(9):2101-6. PubMed ID: 22643192
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.